baber/WOPTO huggingface dataset:
Patent NZ-556750-A (NZ)
Title: Use of o-phenylphenol or salts thereof for protecting plasterboards via an antimicrobial effect
Inventor: KUGLER MARTIN
IPC: E04C2/04
Filed: 2006-02-11
Abstract: Disclosed is the use of o-phenylphenol, or a sodium or potassium salt thereof or mixtures thereof, for protecting plasterboards from attack and/or destruction by micro-organisms, where the plasterboards contain a gypsum core and paper or cardboard outer layers surrounding said core. Also disclosed is antimicrobially treated plasterboard comprising a gypsum core and paper or cardboard outer layers surrounding said core, and containing o-phenylphenol and/or the sodium or potassium salts thereof or mixtures thereof in the core of the plasterboard.
Patent NZ-560453-A (NZ)
Title: 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Inventor: TAVERAS ARTHUR G
IPC: C07D413/14
Filed: 2002-04-15
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are useful in the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
Patent NZ-560689-A (NZ)
Title: Screening method, process for purifying of non-diffusible abeta oligomer, selective antibodies against said non-diffusible abeta oligomers and a process for manufacturing of said antibodies
Inventor: HILLEN HEINZ
IPC: A61K38/17
Filed: 2006-03-03
Abstract: Provided is a method of detecting auto-antibodies having specificity for non-diffusible globular A beta (X - 38 to 43) oligomer structure epitope in a sample derived from a subject, which method comprises contacting the sample with non-diffusible globular A beta (X - 38 to 43) oligomer or a labelled or cross-linked derivative thereof, wherein X is selected from the group consisting of the numbers 1 to 24, and detecting a complex formed by the antibody and the oligomer or derivative, the presence of the complex indicating the presence of the auto-antibodies.
Patent NZ-562415-A (NZ)
Title: Headgear assembly for securement of a nasal pillow mask
Inventor: GUNARATNAM MICHAEL KASSIPILLAI
IPC: A61M16/06
Filed: 2004-02-20
Abstract: A headgear assembly for securing a nozzle assembly of a nasal pillows mask in a desired adjusted position on the face of a patient's head, the nozzle assembly including a base portion and a pair of nozzles projecting from the base portion, and being structured to direct headgear tension forces onto both the underside of the nares of the patient and the top lip of the patient, includes a rear portion formed from a soft and flexible strap material and including an adjustable top strap arrangement structured to pass over a top portion of the patient's head and an adjustable rear strap arrangement structured to pass over a rear portion of the patient's head and a pair of side portions, each side portion being structured to extend from the rear portion towards the nozzle assembly. The adjustable top strap arrangement is structured, via the side portions, to provide a sealing force component operable to pull the pair of nozzles up against the underside of the patient's nares, and the adjustable rear strap arrangement is structured, via the side portions, to provide a stability force component to adjust the stability of the nasal assembly by pulling the nozzle assembly back against the top lip whereby the relative sealing and stability force components are adjustable by selectively varying tension in the adjustable top and rear strap arrangements.
Patent NZ-563340-A (NZ)
Title: Receiving waste anesthetic gas in a chamber which is sent to a vacuum manifold on detection of the gas
Inventor: BERRY JAMES M
IPC: F24F5/00
Filed: 2006-05-11
Abstract: Disclosed is a system for scavenging anaesthetic gas components from waste anaesthetic gas. The system comprises: a chamber (32) having an input and an output in fluid communication with each other; a selectively isolable flow path (34) having a first end portion fluidly coupled to the output of the chamber; and a detector (40) coupled to the chamber. The input of the chamber is coupled to an exhaust (18) of an anesthetizing machine (12) and receives waste anaesthetic gas therefrom which includes an anaesthetic gas component. The selectively isolable flow path has a second end portion adapted to be fluidly coupled to a vacuum manifold (16), the selectively isolable flow selectively isolating the chamber from the vacuum manifold. The detector coupled detects when the waste anaesthetic gas enters and is present in the chamber, the detector coupled to the selectively isolable flow path for control thereof. When the detector detects the gas, it causes the selectively isolable flow path to couple the output of the chamber to the vacuum manifold for evacuation of the gas the chamber into the vacuum manifold.
Patent NZ-572536-A (NZ)
Title: Acidic cleaner for metal surfaces
Inventor: TYBORSKI THOMAS
IPC: C11D1/34
Filed: 2006-05-08
Abstract: Disclosed is an acidic composition for cleaning surfaces of metal or alloys which are susceptible to corrosion comprising i) an ester of phosphoric acid, diphosphoric acid or polyphosphoric acid, ii) a benzotriazole derivative of the general formula (I) wherein which each of the groups R1, R2, R3, R4 and R5 is the same or different and is hydrogen atom, an alkyl group, an alkenyl group, or an acyl group and iii) a phosphonic acid of the general formula R6-PO-(OH)2 (II) in which the group R6 is alkyl group, alkenyl group, aryl group, or arylalkyl group and iv) an acidic source. Also disclosed is an aqueous use composition comprising said acidic composition and a method of cleaning surfaces comprising said composition.
Patent NZ-572681-A (NZ)
Title: Aromatic acetal carboxylic acid derivatives for the treatment of metabolic disorders
Inventor: VON BORSTEL REID W
IPC: A61K31/19
Filed: 2007-05-11
Abstract: Disclosed are phenyl acetal derivatives which are terminally substituted by a carboxylic acid moiety as represented by the general formula (I), wherein n is 1; m is 0-8; q is 0 or 1; t is 0; R1 is alkyl having from 1 to 3 carbon atoms; R2 is hydrogen, halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3 carbon atoms; R3 and R4 together are alkyl having two or three carbon atoms; or R3 and R4 are the same as each other and each is methyl or ethyl; R5 is hydrogen or alkyl having from one to six carbon atoms; A is unsubstituted or substituted phenyl, cycloalkyl or a 5 or 6 membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S or O; or a pharmaceutically acceptable salt of the compound. Further disclosed is a pharmaceutical composition which comprises a compound as defined above and a pharmaceutically acceptable carrier for use in the treatment of a condition selected from the group consisting of insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis or arteriosclerosis. .
Patent NZ-576037-A (NZ)
Title: Deep drawing container with a lid and a bottom each with a thermally shrinkable multi-layered film
Inventor: ISHII HITOSHI
IPC: B65D1/22
Filed: 2007-09-28
Abstract: A deep-drawing packaging container is disclosed. The container comprises a lid member comprising a first thermally shrinkable multi-layered film and a bottom member comprising a second thermally shrinkable multi-layered film. The packaging container is deep-drawing-moulded so that the drawing ratio in the lid member (D1) and that in the bottom member (D2) satisfy the following requirements: · D1 = 1.1 to 4.0, D2 = 1.5 to 5.0, and · (D2/D1) = 1.05 to 4.55. In the packaging container, the boiling water shrinkage ratio in a vertical direction (SM1) and that in a lateral direction (ST1) of the first thermally shrinkable multi-layered film; and the boiling water shrinkage ratio in a vertical direction (SM2) and that in a lateral direction (ST2) of the second thermally shrinkable multi-layered film satisfy the following requirements: · SM1 = 5 to 40%, ST1 = 5 to 40%, · SM2 = 2 to 25%, · ST2 = 2 to 25%, (SM1/SM2) = 1.2 to 12, and · (ST1/ST2) = 1.2 to 12 wherein, the boiling water shrinkage ratio refers to a shrinkage ratio (%) as determined after immersing an undrawn thermally shrinkable multi-layered film in boiling water of 900C for 10 seconds.
Patent NZ-578184-A (NZ)
Title: Insecticide for agricultural or horticultural use and method of use thereof
Inventor: YOSHIDA KEI
IPC: C07D213/81
Filed: 2004-08-23
Abstract: The disclosure relates to aniline derivative compounds represented by formula (9), wherein in the variables shown in the formula are the as defined in the description. These aniline derivatives are used as intermediates in the preparation of agricultural chemicals having insecticidal properties, which also exhibit an excellent preventive effect when being combined with another insecticide, an acaricide, a nematocide, a fungicide, a herbicide, a plant growth regulator, or a biological pesticide. (62) Divided Out of 545547
Patent NZ-580665-A (NZ)
Title: Active ingredient formulations containing 2-thiazole-4yl-1h-benzoimidazol (thiabendazole or tbz) for the production of wpc
Inventor: BOTTCHER ANDREAS
IPC: A01P3/00
Filed: 2008-04-17
Abstract: Disclosed are biocidal mixtures comprising 3-iodo-2-propinyl N-butylcarbamate (IPBC), thiabendazole (TBZ) and at least one separating agent selected from the group of pyrogenic silica. Also disclosed is the use of the biocidal mixture for the protection of wood-plastic composites (WPC) containing thennoplastic polymer and wood particles, against attack and/or destruction by microorganisms. A process for preparing the WPC is also disclosed.
Patent NZ-584499-A (NZ)
Title: Azaindoles Useful as Inhibitors of Jak and Other Protein Kinases
Inventor: SALITURO FRANCESCO
IPC: C07D471/04
Filed: 2005-03-30
Abstract: Disclosed is a 3-aryl-pyrrolo[2,3-b]pyridine derivative of formula I or pharmaceutically acceptable salts thereof, wherein the moiety of formula 2 is selected from formula 2a-e and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula I in the manufacture of a medicament for inhibiting JAK-3, ROCK or Aurora kinase activity.
Patent NZ-584844-A (NZ)
Title: machine for cleaning, washing, drying and ironing clothes and garments, hermetically sealed and equipped with hanging elements
Inventor: ZAGLIO SERGIO
IPC: A47G25/14
Filed: 2008-10-07
Abstract: Disclosed is a multifunction machine for laundries. The machine comprises a body or frame (11 ) defining a treatment chamber (12) hermetically closed and equipped with several means (15) for hanging elements (14) comprising bed linen, clothes and garments, to be treated. A wash and rinse for removing stains with the help of a fluid are provided. The machine has means for drying and for ironing the elements while they are hanging and stretched out in the treatment chamber. The means for hanging elements are of different sizes to support different sized clothes and to hold each element, so that each element is stretched, and its front is separated from its back.
Patent NZ-585916-A (NZ)
Title: A drum winch with a freefall adaptor assembly
Inventor: FORSTER DEAN ROBERT
IPC: B66D1/16
Filed: 2008-11-12
Abstract: Disclosed is a drum winch includes a mounting bracket, a drive shaft arranged to be mounted to the mounting bracket and further arranged for coupling to a drive unit. The drum winch further includes a drum on which rode can be wound. The drum is mounted on the drive shaft. The winch includes means for moving the drum along the drive shaft from a first position to a second position. The drum is arranged so that in the first position rotation of the drive shaft is transmitted to the drum and in the second position the drum is free to rotate relative to the drive shaft.
Patent NZ-587549-A (NZ)
Title: 6-Amino-indole derivatives and processes for their preparation
Inventor: HADIDA RUAH SARAH S
IPC: A61K31/47
Filed: 2005-06-24
Abstract: Disclosed is compound B-24. Also disclosed is a process for the preparation of compound LL comprising contacting compound KK with Raney Ni in the presence of hydrogen gas.
Patent NZ-590406-A (NZ)
Title: Topical medicament comprising sea salt
Inventor: O GORMAN PETER
IPC: A61K33/06
Filed: 2008-07-11
Abstract: 590406 Disclosed is the use of 5 to 35 per cent of at least one soluble salt of a biologically acceptable alkali metal or alkaline earth metal and a pharmaceutically acceptable carrier in the manufacture of a topical medicament for relieving muscle soreness or stiffness or tired muscles, wherein the topical medicament is in the form of a cream, lotion, ointment, liniment, gel, poultice, cold or hot compress, dressing or plaster cast, and wherein the at least one soluble salt is sea salt.
Patent NZ-591666-A (NZ)
Title: Composite wipe having spunbond-meltblown-spunbond (SMS) web layer of continuous fibers and non-woven web layer of discontinuous fibers
Inventor: DAMAGHI ROBIN
IPC: B32B27/02
Filed: 2009-09-04
Abstract: A wipe having a multi-layer structure which is suitable for sanitary purposes is disclosed, wherein the wipe comprises: first and second non-woven web layers of discontinuous fibers which comprise rayon fibers, natural fibers and polymeric fibers, the first and second non-woven web layers being hydrophilic; anda spunbond-meltblown-spunbond web layer of continuous fibers disposed between the first and second non-woven web layers and positioned in facing and adjacently contacting relation with the first and second non-woven web layers, wherein the spunbond-meltblown-spunbond web layer comprises polypropylene or polylactide, and wherein at least one of the first and second non-woven web layers is bonded to the spunbond-meltblown-spunbond web layer by hydroentanglement, and wherein the wipe has an opacity index of at least 1.3, where the opacity index is calculated based on the following equation:opacity index = (opacity of the wipe)/(total basis weight of the wipe).
Patent NZ-592064-A (NZ)
Title: Headgear for masks
Inventor: FORMICA JUSTIN
IPC: A61M16/06
Filed: 2009-12-10
Abstract: 592064 Headgear with at least one strap including first and second surfaces that meet to form a rounded edge is disclosed. The strap is for holding a respiratory mask in position on a patient’s face. The strap provides substantially reduced facial marking in use. In addition, the thermoformed and ultrasonically cut edges are softer and less abrasive, which provides a more comfortable feel on the patent’s face in use, e.g., more comfortable feel around the patient’s ears.
Patent NZ-595146-A (NZ)
Title: Plastic containers with barrier coating comprising an oxyfluorination step and a polyvinyl alcohol application step
Inventor: FUSS ROBERT
IPC: C08J7/048
Filed: 2011-09-12
Abstract: Disclosed is a process for reducing the gas permeability of a plastic material by applying a barrier coating on the plastic material comprising the steps a) pre-treatment of at least a part of the plastic material by oxyfluorination, b) applying at least one coating layer of polyvinyl alcohol on the pre-treated surface, and c) applying at least one top coating layer of polyvinyl acetal on the polyvinyl alcohol layer.
Patent NZ-597164-A (NZ)
Title: Method of drug delivery
Inventor: YU CHRIS C
IPC: A61K9/52
Filed: 2010-07-03
Abstract: Disclosed is a micro-carrier suitable for delivering a drug to a live biological system comprising: (a) a micro-container containing the drug to be delivered; (b) a sensor that is integrated to the micro-carrier and capable of scanning a general area in the live biological system detecting at least one property of the general area at a microscopic level, collecting data thereof which is then processed to determine a targeted site for selectively attaching the micro-carrier to the targeted site for drug release; or, alternatively, a material that is capable of absorbing or adsorbing the micro-carrier to a surface of a targeted site for drug release; and (c) an injector attached to the micro-container for delivering the drug from the micro-container to the targeted site.
Patent NZ-597628-A (NZ)
Title: Hla-b5801 allele associated with adverse drug reactions and methods for detecting such
Inventor: CHEN YUAN-TSONG
IPC: C12Q1/68
Filed: 2007-05-11
Abstract: 597628 Disclosed is a method of assessing a risk of a human patient for developing an adverse drug reaction in response to a drug, comprising: Detecting the presence of HLA-B*5801 in a sample obtained from the patient; and Correlating the presence of HLA-B*5801 in the sample with an increased risk for an adverse drug reaction in the patient in response to the drug, wherein the adverse drug reaction is Stevens-Johnson syndrome or toxic epidermal necrolysis and the drug is oxypurinol.
Patent NZ-600725-A (NZ)
Title: Methods and compositions for delivery of nucleic acids
Inventor: ISMAIL MAHMOUD HAFEZ
IPC: A61K9/133
Filed: 2010-12-17
Abstract: Disclosed is a lipid particle comprising a first cationic lipid, a second cationic lipid, a neutral lipid, and a lipid capable of reducing aggregation; wherein the first cationic lipid is selected on the basis of a first property and the second cationic lipid is selected on the basis of a second property., wherein the first property is a measured value of pK. falling within a first range, and the second property is a measured value of pK. falling within a second range, and wherein when the first cationic lipid and the second cationic lipid are combined the measured value of the pK. is no less than 6.1 and no greater than 6.7.
Patent NZ-613038-A (NZ)
Title: Compact closed-loop electrolyzing process and apparatus
Inventor: KUIPHOFF JOHN
IPC: C02F1/461
Filed: 2011-12-09
Abstract: Disclosed is an electrolytic apparatus and process for the production of Hypochlorous Acid (HClO) and Sodium Hydroxide (NaOH) in a closed-loop arrangement. A brine solution in an electrolyser cell (30) is subjected to an electric current, causing HClO and /or NaOH to be produced in water circulated through the cell (30). The electrolyser cell (30) includes a brine chamber arranged to hold a solution of sodium chloride (NaCl) and water, a first ionizing chamber for the production of HClO, a second ionizing chamber for the production of NaCl, a first electrode, arranged in the first ionizing chamber, a second electrode, arranged in the second ionizing chamber, and two pumps for circulating the solution in two close loops. The produced solution is recirculated through the cell as its chemical properties are monitored by a sensor (25), connected by a controller (60) which controls a recirculating pump (20) and the electric current, until the sensor (25) indicates that the concentration of the solution has reached a desired value, and the controller (60) stops the process.
Patent NZ-614326-A (NZ)
Title: Substituted n-aryl pyridinones
Inventor: ZHANG CHENGZHI
IPC: C07D213/64
Filed: 2012-03-06
Abstract: The disclosure relates to the use of deuterated pirfenidone (compound (I), wherein at least one of R1 – R11 is deuterium), wherein the d-pirfenidone is administered orally between 30 minutes prior to and 2 hours after consuming food. The deuterated pirfenidone may be d3-pirfenidone and the administration with food is to reduce the incidence of gastrointestinal upset, nausea, fatigue, somnolence, dizziness, headache and photosensitivity rash and to reduce the mean maximum plasma concentration.
Patent NZ-619691-A (NZ)
Title: Air cushion inflation machine
Inventor: CHUBA LARRY
IPC: B65D81/05
Filed: 2012-07-06
Abstract: A machine for converting a web (10) of preformed pouches (26) into inflated cushions (12) or dunnage units. The pouches are defined by transverse seals (24) extending from a remote edge (18) to within a predetermined distance from an inflation edge (20). The machine includes a tensioning device (not shown) for frictional engagement with the web, an inflation arrangement (160) for inflation of the preformed pouches, a sealing arrangement (162), and a clamping arrangement (110). The sealing arrangement may be positioned to provide a longitudinal seal (42) that intersects the transverse seals to close the preformed pouches and form the cushion. The sealing arrangement comprises at least two sealing belts positioned to engage the surface of the web and pull the web through sealing elements positioned on either side of the web. The clamping arrangement may comprise at least two pinching belts positioned to engage the surface of the web and pull the web through the sealing elements, wherein the two sealing belts are disposed between the two pinching belts and the inflation edge. The clamping arrangement may prevent the air pressure within the inflated cushion from degrading the quality of the longitudinal seal. The tensioning device holds the web taught during downstream travel.
Patent NZ-624660-A (NZ)
Title: Improvements in and relating to the aeration of fluids
Inventor: BRUCE HENLEY
IPC: C02F7/00
Filed: 2014-05-07
Abstract: An Aeration disc is dislcosed. It may be assembled from like parts that form sectors of the disc. Aeration disc efficiency lies in their ability to introduce air into the water, promote flow of the water as well as to minimize spray and/or splashing. It will be appreciated that spraying/splashing water, particular in regard to waste water, should be avoided. The water aeration disc (1) includes a hub portion (2) providing a rotational axis (A) through the center of the disc and a fluid engaging surface on each side of the disc. The fluid engaging surfaces of the disc including a plurality of fluid engaging structures. The fluid engaging structures are arranged in a common rotational direction (R) on the fluid engaging surfaces and wherein each fluid engaging structure defines a raised surface on one side of the disc and a recessed surface on the opposite side of the disc.
Patent NZ-626089-A (NZ)
Title: Phenylpyrrole derivative
Inventor: NAKAMURA TOSHIO
IPC: C07D491/107
Filed: 2012-12-07
Abstract: Provided is a compound or a pharmaceutically acceptable salt thereof which is useful for the prevention or treatment of diseases such as dementia, Alzheimer’s disease, attention deficit hyperactivity disorder, schizophrenia, epilepsy, central convulsion, obesity, diabetes, hyperlipidemia, narcolepsy, idiopathic hypersomnia, behaviorally induced insufficient sleep syndrome, sleep apnea syndrome, circadian rhythm disorder, parasomnia, sleep-related movement disorder, insomnia, depression or allergic rhinitis. Specifically, provided is a phenylpyrrole derivative or a pharmaceutically acceptable salt thereof represented by formula (I). In formula (I), Q is a group represented by formula (A) or (B).
Patent NZ-705644-A (NZ)
Title: Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
Inventor: SHAN BEI
IPC: C07K16/40
Filed: 2008-08-22
Abstract: Disclosed is an isolated monoclonal antibody that binds to PCSK9, wherein the isolated monoclonal antibody binds an epitope on PCSK9 comprising at least one of residues 237 or 238 of SEQ ID NO: 3, and wherein the monoclonal antibody blocks binding of PCSK9 to LDLR.
Patent NZ-720442-A (NZ)
Title: A fish way
Inventor: Wright Shane
IPC: E02B8/08
Filed: 2010-08-10
Abstract: A fish way for installation on the bed of a water-flow comprising a perforate hollow weir 1 defining a substantially enclosed space, with an upstream surface and a downstream surface and having a base adapted to the bed of a water-flow to define a chamber. There are two or more perforations in the upstream surface and one or more perforations in the downstream surfaces. The upstream and downstream surfaces each contain perforations 6. The perforations in the upstream surface provide for water inflow into the chamber at a rate greater than water outflow from the perforations in the downstream surface of the weir